To include your compound in the COVID-19 Resource Center, submit it here.

BM32: Ph IIb data

Top-line data from 124 evaluable grass pollen-allergic patients in a double-blind, Austrian Phase IIb trial showed that once-monthly 80

Read the full 190 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE